Tiger Eye Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GLIBA
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
|
+$61.9M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$16.2M |
| 3 |
Mastercard
MA
|
+$15.5M |
| 4 |
Atlassian
TEAM
|
+$13.6M |
| 5 |
SMAR
Smartsheet Inc.
SMAR
|
+$13.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Take-Two Interactive
TTWO
|
+$20.4M |
| 2 |
INXN
Interxion Holding N.V.
INXN
|
+$12.2M |
| 3 |
Hilton Worldwide
HLT
|
+$9.79M |
| 4 |
PayPal
PYPL
|
+$9.07M |
| 5 |
Vail Resorts
MTN
|
+$7.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 34.57% |
| 2 | Technology | 31.1% |
| 3 | Healthcare | 12.9% |
| 4 | Financials | 12.27% |
| 5 | Consumer Discretionary | 5.75% |
Similar funds
Tiger Eye Capital's Q1 2019 Portfolio in Review
As of Q1 2019, Tiger Eye Capital held 44 positions worth $412M, up 74% from $237M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Tiger Eye Capital deployed $122M of net new capital in Q1 2019, opening 16 new positions and adding to 8 existing holdings. Its largest new stake was Thermo Fisher Scientific: 64,941 shares worth $17.8M.
By sector, the portfolio is most concentrated in Communication Services at 35% of assets, down from 37% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Take-Two Interactive, an estimated $20.4M trimmed.
- Tiger Eye Capital's largest Q1 2019 buy was Thermo Fisher Scientific: 64,941 shares worth $17.8M.
- Tiger Eye Capital added most to GCI Liberty, Inc. Class A Common Stock (DE) in Q1 2019, an estimated $61.9M increase.
- Tiger Eye Capital's biggest Q1 2019 reduction was Take-Two Interactive, cutting an estimated $20.4M.
- Tiger Eye Capital's ten largest holdings make up 63% of its $412M portfolio in Q1 2019.
- Tiger Eye Capital opened 16 new positions and closed 0 in Q1 2019.
- Tiger Eye Capital's portfolio value rose 74% quarter-over-quarter to $412M.
Based on Tiger Eye Capital's 13F filing for Q1 2019, filed 15 May 2019.